Screening for trisomy 21 by combined biological markers and ultrasound;DESPISTAGE DE LA TRISOMIE 21 PAR ASSOCIATION DES MARQUEURS BIOLOGIQUES ET ECHOGRAPHIQUES

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 26, Issue SUPPL. 3, 1997, Pages 187-189

  Rozenberg, P ^a   Philippe, H J ^a   Perdu, M ^a   Nisand, I ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; GONADOTROPIN; ALPHA FETOPROTEIN;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; FETUS ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; SCREENING TEST; TRISOMY 21; AMNIOCENTESIS; ARTICLE; BLOOD; CLINICAL TRIAL; ECHOGRAPHY; MASS SCREENING; METABOLISM; METHODOLOGY; MULTICENTER STUDY; PREGNANCY; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADULT; ALPHA-FETOPROTEINS; AMNIOCENTESIS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 0030692805     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148 :886-94.
2. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotrophin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7 : 623-30.
3. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynecol 1988;95 :330-3.
4. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA. Maternel serum screening for Down's syndrome in early pregnancy. BMJ 1988;297 :883-7.
5. Spencer K, Coombes EJ, Mallard AS, and A Milfort Ward. Free ß-hCG in Down's syndrome screening : a multicentre study of its role compared with other biochemical markers. Ann Clin Biochem 1992;29 :506-518.
6. Macri JN, Spencer K, Garver K, Buchanan PD, Say B, Carpenter NJ, Muller F, Boué A. Maternal serum free ß-hCG screening : Results of studies including 480 cases of Down syndrome. Prenat Diagn 1994;14 :97-103.
7. Spencer K, Macri JN, Aitken DA, Connor JM. Free ß-hCG as first-trimester maker for fetal trisomy. Lancet 1992;13 :1480.
8. Macri JN, Spencer K, Aitken DA, Garver K, Buchanan PD, Muller F, Boué A. First-trimester free ß-hCG screening for Down syndrome. Prenat Diagn 1993;13 :557-562.
9. Wald NJ, Kennard A, Hackshaw AK. First trimester serum screening for Down's syndrome. Prenat Diagn 1995;15 :1227-40.
10. Hurley PA, Ward RHT, Teisner B, lies RK, Lucas M, Grudzinskas JG. Serum PAPP-A measurements in first-trimester screening for Down syndrome. Prenat Diagn 1993;13 :903-908.
11. Brambati B, Macintosh MC, Teisner B, Maguiness S, Shrimanker K, Lanzani A Bonacchi I, Tului L, Chard T, Grudzinskas JG. Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br J Obstet Gynecol 1993;100 :324-326.
12. Aitken DA, Wallace EM, Crossley JA, et al. Dimeic inhibin A as a marker for Down's syndrome in early pregnancy. N Engl J Med 1996;334 :121-6.
13. Nicolaides KH, Brizot ML, Snijders RJM. Fetal nuchal translucency : ultrasound screening for fetal trisomies in the first trimester of pregnancy. Br J Obstet Gynecol 1994;101 :782-786.
14. Noble PL, Abrama ND, Snijders RJM, Sherwood R, Nicolaides KH. Screening for fetal trisomy 21 in the first trimester of pregnancy : maternal serum free ß-hCG and fetal nuchal translucency thickness. Ultrasound Obstet Gynecol 1995; 6 : 390-395.
15. Brizot ML, Snijders RJM, Bersinger NA, Kuhn P, Nicolaides KH. Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy. Obstet Gynecol 1994;84 : 918-922.
16. Macintosh MCM, Wald MJ, Chard T, Hansen J, Mikkelsen M, Therkelsen AJ, Petersen GB, Lundsteen C. Selective miscarriage of Down's syndrome fetuses in women aged 35 years and older. Br J Obstet Gynecol 1995;102 :798-801.